Sakar Healthcare quarterly results

·UnclassifiedChart ›
Q2 FY27 · Jul–Sep 2026
₹ croreQ2 FY27Q2 FY26Change
Revenue87.457.6+51.9%
EBITDA24.311.4+114.4%
EBITDA margin27.9%19.7%+8.1 pts
Profit before tax16.05.4+199.0%
Net profit11.34.5+149.1%
EPS₹5.08₹2.03+150.2%

Every quarter

₹ crore except per share
Tap a line for its trendQ2 FY27Sep 2026Q1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025Q3 FY25Dec 2024Q2 FY25Sep 2024Q1 FY25Jun 2024Q4 FY24Mar 2024Q3 FY24Dec 2023Earlier quartersAlpha Plus
87.473.071.170.357.652.750.243.442.841.143.137.2
Earlier quartersEvery year the company has filed comes with Alpha Plus.
0.31.50.20.51.20.40.20.30.40.50.80.2
87.774.571.370.958.853.150.443.743.241.643.837.5
Expenses
49.140.035.838.529.628.826.024.922.022.525.920.7
−3.3−5.5−7.4−3.00.80.2−11.4−2.30.9−0.4−1.00.1
9.811.512.99.98.37.515.94.95.55.45.24.5
2.01.72.41.81.52.14.21.31.61.42.11.8
6.66.55.96.45.75.65.55.25.15.14.94.4
7.65.73.56.37.53.54.04.12.93.02.03.0
71.759.953.259.953.447.744.238.238.036.939.034.5
24.321.226.218.611.412.715.711.811.510.711.09.0
17.714.720.312.25.77.110.26.56.45.66.14.6
Profit
16.014.618.111.05.45.46.25.55.14.74.83.0
0.00.00.00.00.00.00.0−0.10.00.00.00.0
16.014.618.111.05.45.46.25.55.14.74.83.0
4.03.96.20.00.00.00.00.00.00.00.00.0
0.70.40.80.70.80.70.50.90.32.31.70.9
4.74.37.00.70.80.70.50.90.32.31.70.9
11.310.311.010.24.54.75.84.54.82.43.12.1
11.310.311.010.24.54.75.84.54.82.43.12.1
−0.0−0.0−0.0−0.0−0.0−0.00.0−0.1−0.1−0.00.1−0.1
11.310.311.010.24.54.65.84.54.72.43.22.0
——11.0—————————
Per share
₹5.08₹4.62₹4.96₹4.59₹2.03₹2.11₹2.66₹2.08₹2.17₹1.10₹1.46₹0.98
₹5.08₹4.62₹4.96₹4.59₹2.03₹2.11₹2.66₹2.08₹2.17₹1.09₹1.45₹0.98
Other comprehensive income — detail
−0.0−0.0−0.0−0.0−0.0−0.00.0—————
−0.0−0.0−0.0−0.0−0.0−0.00.1−0.1−0.1−0.00.1−0.1
−0.0−0.0−0.0−0.0−0.0−0.00.0—————
———————−0.0−0.0−0.00.0−0.0
——11.0———————3.2—
Per share — as-filed variants
₹5.08₹4.62₹4.96₹4.59₹2.03₹2.11₹2.66₹2.08₹2.17₹1.10₹1.46₹0.98
₹5.08₹4.62₹4.96₹4.59₹2.03₹2.11₹2.66₹2.08₹2.17₹1.09₹1.45₹0.98
Derived — gross profit (revenue − materials − purchases − Δ inventories)
41.738.442.734.827.223.835.620.819.919.118.116.5
47.7%52.6%60.1%49.5%47.2%45.1%70.8%47.9%46.5%46.4%42.1%44.3%
Adjusted (ex-exceptional items) — derived
16.014.618.111.05.45.46.25.55.14.74.83.0
0.00.00.00.00.00.00.0−0.10.00.00.00.0
11.310.311.010.24.54.75.84.64.82.43.12.1
₹5.08₹4.62₹4.96₹4.59₹2.03₹2.11₹2.66₹2.10₹2.17₹1.10₹1.46₹0.98
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified
AnnualQuarterly₹ CrorePeersMACPOWERSERVOTECHKAPSTONTHEJOBETAMcap ₹2,106 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Revenue from Operations37.243.141.142.843.450.252.757.670.371.173.087.4
Other Income0.20.80.50.40.30.20.41.20.50.21.50.3
Total Income37.543.841.643.243.750.453.158.870.971.374.587.7
Expenses
+ Cost of Materials Consumed20.725.922.522.024.926.028.829.638.535.840.049.1
+ Changes in Inventories0.1-1.0-0.40.9-2.3-11.40.20.8-3.0-7.4-5.5-3.3
+ Employee Benefit Expense4.55.25.45.54.915.97.58.39.912.911.59.8
+ Finance Costs1.82.11.41.61.34.22.11.51.82.41.72.0
+ Depreciation & Amortisation4.44.95.15.15.25.55.65.76.45.96.56.6
+ Other Expenses3.02.03.02.94.14.03.57.56.33.55.77.6
Total Expenses34.539.036.938.038.244.247.753.459.953.259.971.7
EBITDA9.011.010.711.511.815.712.711.418.626.221.224.3
EBIT4.66.15.66.46.510.27.15.712.220.314.717.7
Profit
PBT before Exceptional Items3.04.84.75.15.56.25.45.411.018.114.616.0
+ Exceptional Items0.00.00.00.0-0.10.00.00.00.00.00.00.0
Pretax Income3.04.84.75.15.56.25.45.411.018.114.616.0
+ Current Tax0.00.00.00.00.00.00.00.00.06.23.94.0
+ Deferred Tax0.91.72.30.30.90.50.70.80.70.80.40.7
Tax Expense0.91.72.30.30.90.50.70.80.77.04.34.7
Net Income2.13.12.44.84.55.84.74.510.211.010.311.3
+ Net Income — Continuing Ops2.13.12.44.84.55.84.74.510.211.010.311.3
+ Other Comprehensive Income-0.10.1-0.0-0.1-0.10.0-0.0-0.0-0.0-0.0-0.0-0.0
Total Comprehensive Income2.03.22.44.74.55.84.64.510.211.010.311.3
Net Income to Common—————————11.0——
Per Share
Basic EPS0.981.461.102.172.082.662.112.034.594.964.625.08
Diluted EPS0.981.451.092.172.082.662.112.034.594.964.625.08
Other Comprehensive Income — detail
+ Other Comprehensive Income—————0.0-0.0-0.0-0.0-0.0-0.0-0.0
+ Items NOT to be Reclassified to P&L-0.10.1-0.0-0.1-0.10.1-0.0-0.0-0.0-0.0-0.0-0.0
+ Tax on Items NOT to be Reclassified—————0.0-0.0-0.0-0.0-0.0-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag-0.00.0-0.0-0.0-0.0———————
Comprehensive Income — Owners of Parent—3.2———————11.0——
Per Share — as-filed variants
Basic EPS — Continuing Operations0.981.461.102.172.082.662.112.034.594.964.625.08
Diluted EPS — Continuing Operations0.981.451.092.172.082.662.112.034.594.964.625.08
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit16.518.119.119.920.835.623.827.234.842.738.441.7
Gross Margin %44.3342.1346.3846.4747.8770.8045.1047.1749.4860.0852.6147.68
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)3.04.84.75.15.56.25.45.411.018.114.616.0
− Exceptional Items (reconciliation)0.00.00.00.0-0.10.00.00.00.00.00.00.0
Net Income Adj (tax-effected)2.13.12.44.84.65.84.74.510.211.010.311.3
EPS Adj0.981.461.102.172.102.662.112.034.594.964.625.08
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Paid Up Equity Capital21.721.721.721.721.921.922.222.222.222.222.222.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sakar Healthcare Q2 FY27 results (July–September 2026)

Filed with NSE on Friday, 23 October 2026 at 12:17 pm IST

Sakar Healthcare (NSE: SAKAR) reported its Q2 FY27 results (July–September 2026) on Friday, 23 October 2026 at 12:17 pm IST. Consolidated net profit was ₹11.3 crore, up 149.1% from ₹4.5 crore in Q2 FY26 and up 9.9% from ₹10.3 crore in Q1 FY27. Revenue from operations was ₹87.4 crore, up 51.9% year on year and up 19.8% from the previous quarter.

Q2 FY26 results (a year earlier)
7 November 2025
Q3 FY27 results due by
14 February 2027

Q2 FY27 at a glance · consolidated

Net profit
₹11.3 Cr+149.1% vs Q2 FY26+9.9% vs Q1 FY27
Revenue from operations
₹87.4 Cr+51.9% vs Q2 FY26+19.8% vs Q1 FY27
Operating margin (EBIT)
20.3%+10.4 pts vs Q2 FY26+0.1 pts vs Q1 FY27EBIT ₹17.7 Cr
EBITDA
₹24.3 Cr+114.4% vs Q2 FY26+14.6% vs Q1 FY27margin 27.8%
Earnings per share (basic)
₹5.08+150.2% vs Q2 FY26+10.0% vs Q1 FY27
Net profit margin
12.9%+5.0 pts vs Q2 FY26−1.2 pts vs Q1 FY27

Questions

What was Sakar Healthcare's net profit in Q2 FY27?

Consolidated net profit was ₹11.3 crore, up 149.1% from ₹4.5 crore in Q2 FY26 and up 9.9% from ₹10.3 crore in Q1 FY27.

What was Sakar Healthcare's revenue in Q2 FY27?

Revenue from operations was ₹87.4 crore, up 51.9% year on year and up 19.8% from the previous quarter.

What is Sakar Healthcare's net profit margin?

Sakar Healthcare's net profit margin was 12.9% in Q2 FY27 (net profit as a share of revenue from operations), against 7.9% in Q2 FY26 (up 5.0 percentage points). For FY26 as a whole it was 12.1%.

How were Sakar Healthcare's Q2 FY27 results?

Both grew from a year earlier: net profit was up 149.1% at ₹11.3 crore and revenue was up 51.9% at ₹87.4 crore. The operating margin was 20.3%, up 10.4 percentage points from 9.9% a year earlier. Against Q1 FY27, net profit was up 9.9% and revenue up 19.8%.

What was Sakar Healthcare's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹17.7 crore, a margin of 20.3%, against 20.2% in Q1 FY27 and 9.9% in Q2 FY26. EBITDA was ₹24.3 crore, 27.8% of revenue.

What was Sakar Healthcare's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹21.6 crore, up 134.4% from ₹9.2 crore in the same months a year earlier. Revenue from operations was ₹160 crore, up 45.4%.

What was Sakar Healthcare's EPS in Q2 FY27?

Basic earnings per share were ₹5.08, against ₹2.03 in Q2 FY26.

What was Sakar Healthcare's revenue in FY26?

Revenue from operations was ₹252 crore in FY26 (April 2025–March 2026), up 41.8% from ₹178 crore in FY25. It was ₹153 crore in FY24 and ₹133 crore in FY23: up 88.8% over three years, 23.6% a year on average.

When did Sakar Healthcare announce its Q2 FY27 results?

On Friday, 23 October 2026 at 12:17 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 7 November 2025.

How has Sakar Healthcare's profit changed over the last four quarters?

Net profit by quarter: ₹10.2 crore in Q3 FY26, ₹11 crore in Q4 FY26, ₹10.3 crore in Q1 FY27 and ₹11.3 crore in Q2 FY27. That is ₹42.9 crore over the four quarters, up 119.8% from ₹19.5 crore in the four quarters before. Revenue from operations: ₹70.3 crore, ₹71.1 crore, ₹73 crore and ₹87.4 crore.

What was Sakar Healthcare's net profit in FY26?

Consolidated net profit was ₹30.5 crore in FY26 (April 2025–March 2026), up 74.2% from ₹17.5 crore in FY25. It was ₹11.7 crore in FY24 and ₹12.8 crore in FY23: up 138.9% over three years, 33.7% a year on average.

When will Sakar Healthcare announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Sakar Healthcare figures come from?

From Sakar Healthcare's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 23 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.